BURFIRALIMAB
UNII 82WF2WG4MP

Substance Identification & Data

This profile provides standardized clinical and technical data for Burfiralimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 82WF2WG4MP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2460809-80-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
82WF2WG4MP
CAS Registry Number
2460809-80-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BURFIRALIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11669
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Burfiralimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BURFIRALIMAB

Common Names & Synonyms

BURFIRALIMAB [INN]
IMMUNOGLOBULIN G4, ANTI-(HUMAN VIMENTIN) (HUMAN-MUS MUSCULUS .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS .KAPPA.-CHAIN, DIMER